Dynamic distribution and expression in vivo of human endostatin gene delivered by adenoviral vector

Life Sciences

Volumn 77, Issue 12, 2005, Pages 1331-1340

  He, Guo An ^a   Xue, Gang ^a,b   Xiao, Lin ^a   Wu, Jiang Xue ^a   Xu, Ben Ling ^a   Huang, Jia Ling ^a   Liang, Zhi Hui ^a   Xiao, Xia ^a   Huang, Bi Jun ^a   Liu, Ran Yi ^a   Huang, Wenlin ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b CHENGDU MILITARY GENERAL HOSPITAL   (China)

Author keywords

Antiangiogenesis; Endostatin; Gene therapy; Recombinant adenovirus

Indexed keywords

ADENOVIRUS VECTOR; ENDOSTATIN; VIRUS DNA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG TISSUE LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; LIVER; MALE; MOUSE; NONHUMAN; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TUMOR; VIRAL GENE DELIVERY SYSTEM; VIRUS RECOMBINANT;

ADENOVIRIDAE; CELL LINE, TUMOR; ENDOSTATINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; HUMANS; INJECTIONS; LIVER; MELANOMA, EXPERIMENTAL; NEOPLASM TRANSPLANTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

ADENOVIRIDAE;

EID: 21744444426     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2005.01.023     Document Type: Article

References (31)

1. A. Alonso, P. Martin, C. Albarran, P. Garcia, O. Garcia, L.F. de Simon, J. Garcia-Hirschfeld, M.S. Ancho, C. de La Rua, and J. Fernandez-Piqueras Real-time PCR designs to estimate nuclear and mitochondrial DNA copy number in forensic and ancient DNA studies Forensic Science International 139 2004 141 149
2. T. Boehm, J. Folkman, T. Browder, and M.S. O'Reilly Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance Nature 390 1997 404 407
3. C. Chartier, E. Degryse, M. Gantzer, A. Dieterle, A. Pavirani, and M. Mehtali Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli Journal of Virology 70 1996 4805 4810
4. P.C. Colorado, A. Torre, G. Kamphaus, Y. Maeshima, H. Hopfer, K. Takahashi, R. Volk, E.D. Zamborsky, S. Herman, P.K. Sarkar, M.B. Ericksen, M. Dhanabal, M. Simons, M. Post, D.W. Kufe, R.R. Weichselbaum, V.P. Sukhatme, and R. Kalluri Anti-angiogenic cues from vascular basement membrane collagen Cancer Research 60 2000 2520 2526
5. R.G. Crystal The body as a manufacturer of endostatin Nature Biotechnology 17 1999 336 337
6. I. Ding, J.Z. Sun, B. Fenton, W.M. Liu, P. Kimsely, P. Okunieff, and W. Min Intratumoral administration of endostatin plasmid inhibits vascular growth and perfusion in MCa-4 murine mammary carcinomas Cancer Research 61 2001 526 531
7. A.L. Feldman, N.P. Restifo, H.R. Alexander, D.L. Bartlett, P. Hwu, P. Seth, and S.K. Libutti Antiangiogenic gene therapy of cancer utilizing a recombinant adenovirus to elevate systemic endostatin levels in mice Cancer Research 60 2000 1503 1506
8. J. Folkman Anti-angiogenesis: new concept for therapy of solid tumors Annals of Surgery 175 1972 4009 4016
9. J. Folkman What is the evidence that tumors are angiogenesis dependent? Journal of the National Cancer Institute 82 1990 4 6
10. J. Folkman Angiogenesis in cancer, vascular, rheumatoid and other disease Nature Medicine 1 1995 27 31
11. J. Folkman Antiangiogenic gene therapy Proceedings of the National Academy of Sciences of the United States of America 95 1998 9064 9066
12. J. Folkman, and P.A. D'Amore Blood vessel formation: what is its molecular basis? Cell 87 1996 1153 1155
13. D. Hanahan, and J. Folkman Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis Cell 86 1996 353 364
14. G.A. He, J.X. Luo, T.Y. Zhang, F.Y. Wang, and R.F. Li Canstatin-N fragment inhibits in vitro endothelial cell proliferation and suppresses in vivo tumor growth Biochemical and Biophysical Research Communications 312 2003 801 805
15. G.A. He, J.X. Luo, T.Y. Zhang, Z.S. Hu, and F.Y. Wang The C-terminal domain of canstatin suppresses in vivo tumor growth associated with proliferation of endothelial cells Biochemical and Biophysical Research Communications 318 2004 354 360
16. W. Huang, and S.J. Flint The tripartite leader sequence of subgroup C adenovirus major late mRNAs can increase the efficiency of mRNA export Journal of Virology 72 1998 225 235
17. W. Huang, and S.J. Flint Unusual properties of adenovirus E2E transcription by RNA polymerase III Journal of Virology 77 2003 4015 4024
18. X. Jin, R. Bookstein, K. Wills, J. Avanzini, V. Tsai, D. LaFace, G. Terracina, B. Shi, and L.L. Nielsen Evaluation of endostatin antiangiogenesis gene therapy in vitro and in vivo Cancer Gene Therapy 8 2001 982 989
19. G.D. Kamphaus, P.C. Colorado, D.J. Panka, H. Hopfer, R. Ramchandran, A. Torre, Y. Maeshima, J.W. Mier, V.P. Sukhatme, and R. Kalluri Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth The Journal of Biological Chemistry 275 2000 1205 1209
20. H.L. Kong Crystal RG. Gene therapy strategies for tumor antiangiogenesis Journal of the National Cancer Institute 90 1998 273 286
21. L. Li, J.L. Huang, Q.C. Liu, P.H. Wu, R.Y. Liu, Y.X. Zeng, and W.L. Huang Endostatin gene therapy for liver cancer by a recombinant adenovirus delivery World Journal of Gastroenterology 10 2004 1867 1871
22. B. Lowe, H.A. Avila, F.R. Bloom, M. Gleeson, and W. Kusser Quantitation of gene expression in neural precursors by reverse-transcription polymerase chain reaction using self-quenched fluorogenic primers Analytical Biochemistry 315 2003 95 105
23. Y. Maeshima, P.C. Colorado, and R. Kalluri Two RGD-independent alpha vbeta 3 integrin binding sites on tumstatin regulate distinct anti-tumor properties The Journal of Biological Chemistry 275 2000 23745 23750
24. Y. Maeshima, A. Sudhakar, J.C. Lively, K. Ueki, S. Kharbanda, C.R. Kahn, N. Sonenberg, R.O. Hynes, and R. Kalluri Tumstatin, an endothelial cell-specific inhibitor of protein synthesis Science 295 2002 140 143
25. M.S. O'Reilly, L. Holmgren, Y. Shing, C. Chen, R.A. Rosenthal, M. Moses, W.S. Lane, Y. Cao, E.H. Sage, and J. Folkman Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma Cell 79 1994 315 328
26. M.S. O'Reilly, T. Boehm, Y. Shing, N. Fukai, G. Vasios, W.S. Lane, E. Flynn, J.R. Birkhead, B.R. Olsen, and J. Folkman Endostatin: an endogenous inhibitor of angiogenesis and tumor growth Cell 88 1997 277 285
27. E. Regulier, S. Paul, M. Marigliano, J. Kintz, Y. Poitevin, C. Ledoux, D. Roecklin, G. Cauet, V. Calenda, and H.E. Homann Adenovirus-mediated delivery of antiangiogenic genes as an antitumor approach Cancer Gene Therapy 8 2001 45 54
28. S.M. Reid, N.P. Ferris, G.H. Hutchings, Z. Zhang, G.J. Belsham, and S. Alexandersen Detection of all seven serotypes of foot-and-mouth disease virus by real-time, fluorogenic reverse transcription polymerase chain reaction assay Journal of Virological Methods 105 2002 67 80
29. B.V. Sauter, O. Martinet, W.J. Zhang, J. Mandeli, and S.L. Woo Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases Proceedings of the National Academy of Sciences of the United States of America 97 2000 4802 4807
30. J. Szary, and S. Szala Intra-tumoral administration of naked plasmid DNA encoding mouse endostatin inhibits renal carcinoma growth International Journal of Cancer 91 2001 835 839
31. J. Yamamoto, K. Ihara, H. Nakayama, S. Hikino, K. Satoh, N. Kubo, T. Iida, Y. Fujii, and T. Hara Characteristic expression of aryl hydrocarbon receptor repressor gene in human tissues: organ-specific distribution and variable induction patterns in mononuclear cells Life Sciences 74 2003 1039 1049